[Accuracy of the 64 multislice computed tomography in the diagnosis of coronary stent restenosis]. / Precisión de la tomografía de 64 cortes en el diagnóstico de reestenosis de stent coronario.

OBJECTIVE: To determine the accuracy of coronary angiography through 64-slice computed tomography in detecting in-stent restenosis. METHOD: Fifty-two patients with 76 coronary stents and suspicion of restenosis were examined. Initially, they underwent coronary angiography through 64-slice computed tomography, and subsequently invasive coronary angiography as gold standard. Diagnostic efficiency indexes were calculated. RESULTS: In the stents of 3 mm or more of diameter, tomography sensitivity, specificity, positive and negative predictive value were 95, 98, 95 and 98% respectively, with positive likelihood ratio of 42 (CI95%, 6 to 290) and negative of 0.05 (CI95%, .01 to .35), validity of 97% and Kappa of 0.93 (CI95%, .83 to 1), (p ? 0.00001). In the stents smaller than 3 mm, the indexes of diagnostic efficiency and Kappa considerably decreased, loosing the statistical significance (p >0.05). CONCLUSIONS: Coronary angiography through 64-slice computed tomography is an accurate, non-invasive clinical technique for the detection of in-stent restenosis, especially with stents of 3 mm or more of diameter, and reliable allows identification of patients who need to undergo or not control invasive coronary angiography.

Precisión de la tomografía de 64 cortes en el diagnóstico de reestenosis de stent coronario / Accuracy of the 64 multislice computed tomography in the diagnosis of coronary stent restenosis

Objetivo: Determinar la precisión de la coronariografía por tomografía de 64 cortes para la detección de la reestenosis de los stents. Método: Se examinaron 52 pacientes portadores de 76 stents coronarios con sospecha de reestenosis. Inicialmente se les realizó coronariografía mediante tomógrafo de 64 cortes y posteriormente coronariografía invasiva como patrón de referencia. Se calcularon los índices de eficiencia diagnóstica. Resultados: En los stents valorables de 3 mm o más de diámetro, la sensibilidad, especificidad, valor predictivo positivo y negativo de la tomografía fueron de 95, 98, 95 y 98% respectivamente, con razón de verosimilitud positiva de 42 (IC95%, 6 a 290) y negativa de 0.05 (IC95%, 0.01 a 0.35), validez de 97% y Kappa de 0.93 (IC95%, 0.83 a 1), (p ≤ 0.00001). En los stents valorables menores que 3 mm, disminuyeron apreciablemente los índices de eficiencia diagnóstica y de Kappa, perdiendo la significancia estadística (p > 0.05). Conclusión: La coronariografía por tomografía de 64 cortes es una técnica clínica no invasiva precisa, en la detección de la reestenosis de los stents, sobre todo en los stents de 3 mm o más, y segura, ya que permite identificar a los pacientes que necesitan o no la realización de una coronariografía invasiva de control.

Objective: To determine the accuracy of coronary angiography through 64-slice computed tomography in detecting in-stent restenosis. Method: Fifty-two patients with 76 coronary stents and suspicion of restenosis were examined. Initially, they underwent coronary angiography through 64-slice computed tomography, and subsequently invasive coronary angiography as gold standard. Diagnostic efficiency indexes were calculated. Results: In the stents of 3 mm or more of diameter, tomography sensitivity, specificity, positive and negative predictive value were 95, 98, 95 and 98% respectively, with positive likelihood ratio of 42 (CI95%, 6 to 290) and negative of 0.05 (CI95%, .01 to .35), validity of 97% and Kappa of 0.93 (CI95%, .83 to 1), (p ≤ 0.00001). In the stents smaller than 3 mm, the indexes of diagnostic efficiency and Kappa considerably decreased, loosing the statistical significance (p >0.05). Conclusions: Coronary angiography through 64-slice computed tomography is an accurate, non-invasive clinical technique for the detection of in-stent restenosis, especially with stents of 3 mm or more of diameter, and reliable allows identification of patients who need to undergo or not control invasive coronary angiography.

[Accuracy of 64 slice computed tomography angiography in the diagnosis of ischemic coronary artery disease]. / Precisión de la tomografía de 64 cortes en el diagnóstico de la cardiopatía isquémica.

INTRODUCTION AND OBJECTIVES: Multislice computed tomography coronary angiography (MSCT-CA) has been developed in the last years. One of the advantages is to supply information of the lumen and wall of the vessels. The aim was to assess the diagnostic accuracy of MSCT - CA to detect significant coronary stenoses taking as gold standard the invasive coronary angiography (ICA). PATIENTS AND METHODS: We studied, after informed consent, 64 consecutive patients (50 males). First MSCT - CA was performed and afterwards with a media of 45 days the ICA. Sensitivity (SENS), specificity (ESP), positive predictive value (PPV), negative predictive value (NPV) and predictive precision (PP) were assessed per patients, per arteries and per segments. RESULTS: The SENS, ESP, PPV, PNV and PP were 96.4, 91.2, 87, 96.8, 93.5% respectively per patients and 95.7, 97, 88.2, 98.9, 96.7% respectively per arteries and 91, 99, 89, 99.6, 98.7% respectively per segments. The diagnostic accuracy decreased in patients with heart rate higher than 65 beats per minute, as well as in patients with calcium scoring higher than 400 Agatston Units or body mass index with or higher than 30 kg/m2 CS. CONCLUSIONS: Our results suggest that MSCT - CA has a good accuracy, especially in the ESP and NPV for the diagnosis of significant coronary stenoses in selected patients with calcium scoring of 400 Agatston Units or lower, heart rate with 65 beats per minute or lower with regular rhythm and body mass index lower than 30 kg/m2 CS.

Precisión de la tomografía de 64 cortes en el diagnóstico de la cardiopatía isquémica / Accuracy of 64 slice computed tomography angiography in the diagnosis of ischemic coronary artery disease

INTRODUCTION AND OBJECTIVES: Multislice computed tomography coronary angiography (MSCT-CA) has been developed in the last years. One of the advantages is to supply information of the lumen and wall of the vessels. The aim was to assess the diagnostic accuracy of MSCT - CA to detect significant coronary stenoses taking as gold standard the invasive coronary angiography (ICA). PATIENTS AND METHODS: We studied, after informed consent, 64 consecutive patients (50 males). First MSCT - CA was performed and afterwards with a media of 45 days the ICA. Sensitivity (SENS), specificity (ESP), positive predictive value (PPV), negative predictive value (NPV) and predictive precision (PP) were assessed per patients, per arteries and per segments. RESULTS: The SENS, ESP, PPV, PNV and PP were 96.4, 91.2, 87, 96.8, 93.5% respectively per patients and 95.7, 97, 88.2, 98.9, 96.7% respectively per arteries and 91, 99, 89, 99.6, 98.7% respectively per segments. The diagnostic accuracy decreased in patients with heart rate higher than 65 beats per minute, as well as in patients with calcium scoring higher than 400 Agatston Units or body mass index with or higher than 30 kg/m2 CS. CONCLUSIONS: Our results suggest that MSCT - CA has a good accuracy, especially in the ESP and NPV for the diagnosis of significant coronary stenoses in selected patients with calcium scoring of 400 Agatston Units or lower, heart rate with 65 beats per minute or lower with regular rhythm and body mass index lower than 30 kg/m2 CS.

Coronariografía por tomografía de 64 cortes: Precisión diagnóstica según puntaje de calcio y frecuencia cardíaca / Coronariography by 64-Slice Computed Tomography: Diagnostic Accuracy According to Calcium Score and Heart Rate

Introducción y Objetivos La coronariografía invasiva (CI) es el patrón estándar para el estudio de las coronarias con un bajo índice de complicaciones. La tomografía computarizada multicorte (TCMC) permite el estudio mínimamente invasivo del árbol coronario. El objetivo del presente trabajo estuvo dirigido a determinar la precisión de la TCMC para detectar estenosis coronaria significativa (ECS) según puntaje de calcio y frecuencia cardíaca. Material y métodos Se estudiaron 62 pacientes, 50 del sexo masculino, a los que se les realizó primero la coronariografía por TCMC y luego la CI, con una media de 45 días, previo consentimiento informado. Se determinaron la sensibilidad (S), la especificidad (E), el valor predictivo positivo (VPP), el valor predictivo negativo (VPN) y la precisión predictiva (PP) por paciente y arterias según puntaje de calcio y frecuencia cardíaca. Resultados La S, la E, el VPP, el VPN y la PP por arterias fueron, respectivamente, con puntaje de calcio menor o igual a 400 UA del 98%, 98%, 89%, 99% y 98% y con puntaje mayor de 400 UA, del 75%, 50%, 75%, 50% y 67%. En los 54 pacientes con frecuencia cardíaca menor o igual a 65 latidos por minuto, la S, la E, el VPP, el VPN y la PP fueron del 100%, 96%, 96%, 100% y 98,1% y en los 8 pacientes con frecuencia cardíaca mayor de 65 latidos por minuto fueron del 50%, 66,7%, 33%, 80% y 62,5%, respectivamente. Conclusiones El puntaje de calcio por encima de 400 UA por paciente y arterias, como también la frecuencia cardíaca mayor de 65 latidos por minuto, disminuyen la precisión diagnóstica de ECS a través de la TCMC.

Introduction and Objectives Invasive coronariography (IC) is the gold standard for the study of coronary arteries with a low percentage of complications. Multislice computerized tomography (MSCT) allows the minimally invasive study of the coronary tree. The objective of the present study was aimed at determining the accuracy of MSCT in the detection of significant coronary stenosis (SCS) by calcium score and heart rate. Material and Methods The 62 patients enrolled in the study (50 males) underwent a coronariography with MSCT, and later the IC, with a mean of 45 days, after signature of an informed consent. Sensitivity (Se) was assessed, as well as specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), and predictive accuracy (PA) per patient and arteries, according to calcium score and heart rate. Results Se, Sp, PPV, NPV and PA per arteries, with a calcium score lower or equal to 400 AU were, respectively 98%, 98%, 89%, 99% and 98%, and with a score higher than 400 AU, of 75%, 50%, 75%, 50% and 67%. In 54 patients with heart rate lower or equal to 65 beats per minute, Se, Sp, PPV, NPV and PA were 100%, 96%, 96%, 100% and 98,1% and in the 8 patients with heart rate higher than 65 beats per minute were 50%, 66.7%, 33%, 80% and 62.5%, respectively. Conclusions Calcium score above 400 AU per patient and arteries, as well as the heart rate over 65 beats per minute, decrease the diagnostic accuracy of SCS by means of MSCT.

Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.

PURPOSE: Fibrinolytic therapy restores coronary patency and reduces mortality in patients with acute myocardial infarction. Albumin is present in most of the streptokinase formulation as a stabilizer but it is not known whether it plays a role in the product's efficacy and safety profiles. The aim of this study was to assess 90 minutes-coronary patency of a new albumin-free recombinant streptokinase (rSK) formulation. METHODS . Patients with ischemic chest pain and ST-segment elevation, less than 12 hours after symptoms onset, without contraindications for fibrinolytic therapy, were included to receive 1.5 x 10(6) IU of rSK in a one-hour intravenous infusion. Angiography was performed 90 minutes after and coronary patency was classified according to the TIMI flow scales. RESULTS: The study enrolled 25 patients, 59.4 +/- 9.2 years-old, 88% men and 92% white. The mean time interval between the symptoms onset and rSK infusion was 3.0 +/- 2.0 hours. Patency rate (TIMI 2-3) of the infarct-related vessel was 72% (18/25). Partial or complete ST-segment resolution was achieved in 17 patients (68%). Hypotension and nauseas were the most frequent adverse events. Haemorrhage or in-hospital deaths were not reported. CONCLUSIONS: This study suggests that intravenous albumin-free rSK is a safe and appropriate therapy to get early (90-minute) coronary patency in patients with acute myocardial infarction.